Link to the Show / Show Notes This summary covers the issue of October 5, 2006. Featured are articles on ranibizumab for age-related macular degeneration, ranibizumab versus verteporfin for age-related macular degeneration, immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis, lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion; review articles on the prevention of mengingococcal disease and on age-related macular degeneration; a clinical problem-solving article revealing what was lost in transcription; and Perspective articles on ranibizumab, bevacizumab, and the treatment of macular degeneration, on 100 years of tracing atrial fibrillation, and on accepting the realities of aging.